The medical device industry faces a confluence of existential pressures that demand coordinated response from both individual manufacturers and collective industry voices. With AdvaMed's leadership highlighting cybersecurity vulnerabilities, persistent inflation, and looming trade policy uncertainties, health system executives and medtech vendors alike must prepare for a fundamentally altered competitive landscape in 2026 and beyond.
Mick Farrell's perspective as both AdvaMed chair and ResMed CEO positions him uniquely to articulate the interconnected nature of these challenges. Unlike isolated operational headaches, these three pressures create a cascading effect across the medtech value chain. Cyberattacks don't merely disrupt manufacturing—they threaten hospital supply chains, patient safety, and regulatory compliance simultaneously. Inflation doesn't just raise production costs; it compresses already-thin device margins while simultaneously driving up healthcare labor expenses that hospitals cannot easily control. Trade tariffs, if implemented, would ripple through supply chains that have been optimized over decades for efficiency rather than resilience.
Why This Moment Matters for Health System Leaders
Hospital and health system CIOs and CFOs should recognize that device vendors will face genuine margin pressure in the coming months. This may translate into several outcomes: some companies will accelerate price increases before tariffs take effect, others will seek to streamline their product portfolios, and the weakest players may become acquisition targets. Vendors won't absorb these costs silently—they'll pass them downstream to hospital partners, either through higher device pricing or reduced service commitments.
The cybersecurity dimension carries particular urgency for health systems. As medical devices become increasingly connected and software-driven, the attack surface expands. A single compromised infusion pump or ventilator doesn't just threaten one patient; it can cascade through networked hospital systems. Health system security teams need to demand that device manufacturers prioritize security architecture over feature velocity, yet manufacturers operating on thin margins may resist costly security investments. This creates a prisoner's dilemma where collective industry security depends on individual companies making economically irrational decisions.
Inflation's persistence also reshapes procurement strategies. Health systems that locked in multi-year device contracts during 2023-2024 may find themselves advantaged, while those with expiring agreements face sticker shock. Conversely, vendors who agreed to fixed prices are now struggling with input cost overruns. This misalignment creates tension in relationships historically built on mutual trust.
For medtech vendors, AdvaMed's public articulation of these challenges signals a coordinated advocacy effort ahead. Trade associations typically mobilize around policy threats, but Farrell's framing suggests the industry will pursue multiple strategies: regulatory streamlining to reduce operational costs, supply chain diversification investments, and likely aggressive lobbying against proposed tariffs. Smaller device makers should pay close attention to how larger competitors navigate these pressures, as consolidation often accelerates during periods of uncertainty.
The subtext of AdvaMed's leadership positioning is equally important: the industry is preparing health systems and policymakers for difficult conversations about pricing, innovation investment, and the true cost of medical device development. Farrell's dual role allows him to model how device makers must simultaneously operate as efficient manufacturers and as stewards of healthcare innovation during periods of macroeconomic stress.
Health system leaders should view this moment as an inflection point for vendor negotiations. Those who anticipate inflation, cybersecurity mandates, and supply chain restructuring can negotiate more favorable terms today. Those who wait for tariffs to materialize or for the next major breach will find themselves reacting rather than leading.
Reporting basis: medtechdive.com. Analysis by the HTC editorial desk.